FDA Warns Novartis Over Violations At Indian Drug Plants
Novartis AG on Tuesday said that the U.S. Food and Drug Administration had issued warning letters to its Sandoz Inc. unit earlier this month regarding manufacturing practices at two plants in...To view the full article, register now.
Already a subscriber? Click here to view full article